Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zai Lab Ltd | Head of Global Dev., Oncology | Restricted Share Units | 73K | $1.91M | $26.12 | Jun 25, 2022 | Direct |
ALX ONCOLOGY HOLDINGS INC | Director | Stock Option (right to buy) | 40.4K | Aug 5, 2024 | Direct | ||
Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 35K | Jun 13, 2024 | Direct | ||
Mirati Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
Mirati Therapeutics, Inc. | Chief Medical Officer | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALXO | ALX ONCOLOGY HOLDINGS INC | Aug 5, 2024 | 1 | $0 | 4 | Aug 7, 2024 | Director |
ALXO | ALX ONCOLOGY HOLDINGS INC | Aug 5, 2024 | 0 | $0 | 3 | Aug 7, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 4, 2024 | Director |
ELEV | Elevation Oncology, Inc. | Feb 29, 2024 | 0 | $0 | 3 | Mar 4, 2024 | Director |
MRTX | Mirati Therapeutics, Inc. | Jan 23, 2024 | 4 | $0 | 4 | Jan 23, 2024 | Chief Medical Officer |
MRTX | Mirati Therapeutics, Inc. | Dec 29, 2023 | 1 | $1M | 4 | Jan 3, 2024 | Chief Medical Officer |
MRTX | Mirati Therapeutics, Inc. | Aug 9, 2023 | 1 | $825K | 4 | Aug 10, 2023 | Chief Medical Officer |
MRTX | Mirati Therapeutics, Inc. | Nov 7, 2022 | 2 | $0 | 4 | Nov 8, 2022 | Chief Medical Officer |
MRTX | Mirati Therapeutics, Inc. | Nov 7, 2022 | 0 | $0 | 3 | Nov 8, 2022 | Chief Medical Officer |
ZLAB | Zai Lab Ltd | Jun 25, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Head of Global Dev., Oncology |
ZLAB | Zai Lab Ltd | Apr 1, 2022 | 4 | $0 | 4 | Apr 5, 2022 | Head of Global Dev., Oncology |
ZLAB | Zai Lab Ltd | Dec 1, 2021 | 1 | -$148K | 4 | Dec 3, 2021 | Head of Global Dev., Oncology |